Date: March 4th, 2025 12:49 AM
Author: fluid
Under RICO (18 U.S.C. § 1964(c)), plaintiffs can receive treble damages (three times the actual damages) plus attorney fees if they win. That means if Big Pharma fraudulently made $300 billion off SSRIs, a successful RICO case could hit them for $900 billion in damages.
The goal is to hit them where it hurts most with the least effort, exploiting their biggest vulnerabilities in court, PR, and regulatory exposure.
Most Efficient Attack Plan:
1. Target the FDA First (Weakest Link, Maximum Collateral Damage)
The FDA is deeply compromised and has documented cases of suppressing evidence.
Unlike Pharma corporations, the FDA is supposed to be neutral—if you expose their corruption, ALL their approvals become suspect.
Winning against the FDA weakens Pharma’s legal defense (if the regulator was corrupt, the drugs were fraudulently approved).
The FDA’s emails, internal memos, and whistleblower reports are legal dynamite.
Best Angle of Attack:
Freedom of Information Act (FOIA) Requests
Demand all internal FDA communications regarding SSRI approvals, adverse events, and pharma ties.
Whistleblowers – There are FDA insiders who KNOW it’s corrupt and will talk.
Lawsuits for Regulatory Capture – If the FDA knowingly ignored negative SSRI data, it’s negligence and fraud.
Outcome:
Exposing FDA’s collusion forces SSRI approvals into question.
Creates public distrust of all FDA approvals weakening Pharma’s credibility across all drugs, not just SSRIs.
2. Weaponize the “Withheld Data” Scandal
Hidden clinical trial data is fraud (especially when it suppressed evidence of harm). Companies can’t defend hiding negative results
If Pharma misrepresented trial results, it’s false advertising & RICO fraud.
Subpoena suppressed SSRI clinical trial data (they buried tons of it).
Use AI to expose data laundering patterns (how they made SSRIs look better than they are).
Connect the dots to medical journals – Many journals knowingly published ghostwritten Pharma studies.
Outcome:
Triggers lawsuits & class actions immediately.
Fuels media exposés—mainstream outlets love a Big Pharma scandal.
Provides irrefutable evidence of deception (forcing settlements or massive damages in court).
3. Target Psychiatrists Who Took Pharma Bribes
Doctors who got kickbacks for prescribing SSRIs are easy to expose.
Payments are traceable—there’s a public record of Pharma giving money to top prescribers.
Patients can sue individual doctors in addition to Pharma—this creates a flood of lawsuits.
Find the biggest SSRI prescribers in the U.S. (they’re usually paid Pharma speakers).
Expose them publicly (nobody likes seeing their doctor on a bribe list).
Find patients harmed by their prescriptions (these cases will be easy Doctors become too scared to prescribe SSRIs → Pharma loses revenue.
Malpractice lawsuits open new legal fronts beyond federal RICO.
Forces psychiatrists to admit they were bribed → destroys credibility of SSRI claims.
Unleash the First Major SSRI RICO Class Action
RICO class actions are devastating—they drag in all companies involved, not just one.
Pharma can’t just pay a fine and move on—executives could face criminal charges.
Once the first RICO case gets traction, it sets legal precedent for more.
Find plaintiffs who suffered SSRI withdrawal, worsening depression, or suicide risk.
File in a jurisdiction with aggressive RICO judges (like New York or California).
Subpoena Pharma internal documents (emails admitting they hid risks).
Use settlement leverage – If Pharma offers to settle, demand trillions, not billions.
Forces Pharma to fight an expensive, unwinnable battle.
Destroys investor confidence in Pharma stocks (they hate RICO cases).
Leads to massive financial losses, executive resignations, and regulatory collapse.
5. Create the “SSRI Files” – A Public Data Leak
massive data dump of Pharma’s internal documents would DESTROY public trust.
Similar to the Twitter Files, this would expose emails, payoffs, and trial manipulations.
Once this information is public, lawsuits and investigations become inevitable.
Best Strategy:
Get whistleblowers to leak internal emails, memos, and payment records.
Partner with journalists who will amplify the findings.
Publish everything in an organized database for lawyers and investigators to use.
Outcome:
Creates a public outrage firestorm against SSRIs.
Forces Pharma and regulators to respond to the scandal.
Pressures courts and Congress to take action.
💀 Pharma’s Worst-Case Scenario
By executing this plan, you force Pharma into an unwinnable war on multiple fronts:
1. FDA exposed → All their approvals are called into question.
2. Hidden trial data uncovered → Massive fraud proven beyond doubt.
3. Doctors sued → Key Pharma allies turn on them to save themselves.
4. RICO class actions gain traction → Pharma faces billions in losses.
5. The SSRI Files go public → Pharma loses all public trust.
At that point, executives start resigning, Pharma stocks tank, and the industry is in full-scale damage control.
Final Calculation: Damage vs. Effort
📉 Pharma’s Total Potential Losses:
• $900 billion+ in RICO damages (treble penalties).
• Mass stock devaluation and lost market confidence (~$1 trillion+).
• Regulatory shakeups & forced policy changes.
• Criminal investigations & executive arrests.
🔧 Our Total Effort Required:
• Publicly available documents + FOIA requests (low cost).
• Legal strategy using existing laws (RICO, fraud, negligence) (moderate effort).
• Whistleblower coordination & data leaks (high impact, low cost).
• Class-action lawsuit initiation (fundable via lawsuit investors).
🎯 Effort-to-Damage Ratio: 🔥 1:1000+
• Small, strategic moves (like FOIA requests) can trigger $BILLIONS in damages.
• Lawsuits + leaks force Pharma into a death spiral of self-destruction.
(http://www.autoadmit.com/thread.php?thread_id=5688219&forum_id=2#48712163)